These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16286124

  • 21. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 22. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
    Palma D, Pickles T, Tyldesley S, Prostate Cohort Outcomes Initiative.
    BJU Int; 2007 Aug; 100(2):315-9. PubMed ID: 17617138
    [Abstract] [Full Text] [Related]

  • 23. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
    Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV.
    Cancer; 2007 Apr 15; 109(8):1493-8. PubMed ID: 17340594
    [Abstract] [Full Text] [Related]

  • 24. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML.
    Cancer; 2006 Aug 01; 107(3):521-9. PubMed ID: 16773619
    [Abstract] [Full Text] [Related]

  • 25. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE.
    Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ, CaPSURE Investigators.
    J Urol; 2006 Jan 01; 175(1):125-9; discussion 129. PubMed ID: 16406887
    [Abstract] [Full Text] [Related]

  • 26. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.
    J Urol; 2005 Apr 01; 173(4):1126-31. PubMed ID: 15758720
    [Abstract] [Full Text] [Related]

  • 27. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
    Pfitzenmaier J, Pritsch M, Haferkamp A, Jakobi H, Fritsch F, Gilfrich C, Djakovic N, Buse S, Pahernik S, Hohenfellner M.
    BJU Int; 2009 Apr 01; 103(7):877-82. PubMed ID: 19007372
    [Abstract] [Full Text] [Related]

  • 28. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC.
    Cancer; 2007 Apr 01; 109(7):1273-8. PubMed ID: 17315165
    [Abstract] [Full Text] [Related]

  • 29. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM, Koch MO, Eble JN, Lin H, Cheng L.
    J Urol; 2006 May 01; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [Abstract] [Full Text] [Related]

  • 30. Changing nature of high risk patients undergoing radical prostatectomy.
    Kane CJ, Presti JC, Amling CL, Aronson WJ, Terris MK, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Jan 01; 177(1):113-7. PubMed ID: 17162017
    [Abstract] [Full Text] [Related]

  • 31. Effect of perioperative blood transfusion on prostate cancer recurrence.
    Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL.
    Urol Oncol; 2008 Jan 01; 26(4):364-7. PubMed ID: 18367097
    [Abstract] [Full Text] [Related]

  • 32. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB, Zerbib M, Mejean A, Rouach Y, Debre B, Peyromaure M.
    Can J Urol; 2009 Oct 01; 16(5):4813-9. PubMed ID: 19796456
    [Abstract] [Full Text] [Related]

  • 33. Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases.
    Brown JA, Rodin DM, Lee B, Dahl DM.
    J Urol; 2005 Feb 01; 173(2):442-5. PubMed ID: 15643198
    [Abstract] [Full Text] [Related]

  • 34. The impact of obesity on laparoscopic radical prostatectomy.
    Eden CG, Chang CM, Gianduzzo T, Moon DA.
    BJU Int; 2006 Dec 01; 98(6):1279-82. PubMed ID: 16879436
    [Abstract] [Full Text] [Related]

  • 35. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.
    Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators.
    Urology; 2006 Dec 01; 68(6):1242-7. PubMed ID: 17141841
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E, Drouin SJ, Comperat E, Vaessen C, Renard-Penna R, Misrai V, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Roupret M.
    BJU Int; 2009 May 01; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.